Euroapi Company Header Euroapi Company Header

X

Find the latest Drugs in Development and Pipeline Prospector News of Anglo-French Drugs and industries.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Anglo-French Drugs and industries
india-flag Flag
Country
Country
India
Address
Address
No. 41, 3rd Cross, 5th Block, Rajajinagar, Bengaluru – 560 010, Karnataka
Telephone
Telephone
+(91)-(80)-2315 6722
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

AFD-NP is a combination of Nortriptyline and Pregabalin which has approved for the treatment of moderate to severe neuropathic pain.


Lead Product(s): Pregabalin,Nortriptyline

Therapeutic Area: Neurology Product Name: AFD-NP

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable February 27, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

The acquisition will strengthen Lupin’s business by adding a portfolio of vitamins, minerals, supplements and neurological products. The acquisition of the AFDIL brands takes Lupin further in shaping its portfolio to emerge as a leading pharmaceutical company in India.


Lead Product(s): Nicotinamide

Therapeutic Area: Nutrition and Weight Loss Product Name: Beplex Forte

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Lupin Ltd

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition April 07, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY